- Home
- GBR vs MTNB Comparison
GBR vs MTNB Comparison
Compare GBR & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.79
Company Overview
Basic Information| Metric | GBR | MTNB |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 5.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GBR | MTNB |
|---|---|---|
| Price | $0.85 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.3K | ★ 31.2K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $153,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $0.67 | $0.47 |
| 52 Week High | $1.78 | $3.09 |
Technical Indicators
Market Signals| Indicator | GBR | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 35.88 |
| Support Level | $0.75 | $0.76 |
| Resistance Level | $0.85 | $0.98 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 48.72 | 32.73 |
Price Performance
Historical Comparison GBR
MTNB
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.